Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN® Ebola Vaccine
22 oct. 2014 01h50 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Crucell Holland B.V., one of the Janssen...
Bavarian Nordic indgår licens- og produktionsaftale med Janssen omkring MVA-BN® ebolavaccine
22 oct. 2014 01h50 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Crucell Holland B.V., hørende til Janssen...
Bavarian Nordic Provides Update on Business Activities and Reports Preliminary Interim Financial Results for the First Nine Months of 2014
22 oct. 2014 01h45 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Partnering negotiations ongoing for the...
Bavarian Nordic opdaterer på forretningsaktiviter og fremlægger foreløbige finansielle resultater for de første ni måneder af 2014
22 oct. 2014 01h45 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Igangværende partnerforhandlinger omkring...
Bavarian Nordic A/S - Articles of Association
20 oct. 2014 07h24 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Updated Articles of Association for Bavarian...
Bavarian Nordic A/S - Vedtægter
20 oct. 2014 07h24 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Opdaterede vedtægter for Bavarian Nordic A/S ...
Bavarian Nordic issues Financial Calendar for 2015
23 sept. 2014 02h00 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KVISTGAARD, Denmark, September 23, 2014 -...
Bavarian Nordic offentliggør finanskalender for 2015
23 sept. 2014 02h00 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KVISTGÅRD, Danmark - 23. september 2014 -...
Bavarian Nordic Announces Exercise of Contract Option by the U.S. Government for Continued Supply of IMVAMUNE(r) Smallpox Vaccine
04 sept. 2014 12h18 HE
|
Bavarian Nordic A/S
KVISTGAARD, Denmark, Sept. 4, 2014 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Biomedical Advanced Research and Development Authority (BARDA), a division...
Bavarian Nordic offentliggør udnyttelse af option i kontrakt med den amerikanske regering om fortsatte leverancer af IMVAMUNE® koppevaccine
04 sept. 2014 12h12 HE
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Option på USD 118 mio. bidrager til...